Advertisement

Acta Neuropathologica

, Volume 110, Issue 2, pp 165–172 | Cite as

The unfolded protein response is activated in Alzheimer’s disease

  • J. J. M. HoozemansEmail author
  • R. Veerhuis
  • E. S. Van Haastert
  • J. M. Rozemuller
  • F. Baas
  • P. Eikelenboom
  • W. Scheper
Regular Paper

Abstract

Alzheimer’s disease (AD) is, at the neuropathological level, characterized by the accumulation and aggregation of misfolded proteins. The presence of misfolded proteins in the endoplasmic reticulum (ER) triggers a cellular stress response called the unfolded protein response (UPR) that may protect the cell against the toxic buildup of misfolded proteins. In this study we investigated the activation of the UPR in AD. Protein levels of BiP/GRP78, a molecular chaperone which is up-regulated during the UPR, was found to be increased in AD temporal cortex and hippocampus as determined by Western blot analysis. At the immunohistochemical level intensified staining of BiP/GRP78 was observed in AD, which did not co-localize with AT8-positive neurofibrillary tangles. In addition, we performed immunohistochemistry for phosphorylated (activated) pancreatic ER kinase (p-PERK), an ER kinase which is activated during the UPR. p-PERK was observed in neurons in AD patients, but not in non-demented control cases and did not co-localize with AT8-positive tangles. Overall, these data show that the UPR is activated in AD, and the increased occurrence of BiP/GRP78 and p-PERK in cytologically normal-appearing neurons suggest a role for the UPR early in AD neurodegeneration. Although the initial participation of the UPR in AD pathogenesis might be neuroprotective, sustained activation of the UPR in AD might initiate or mediate neurodegeneration.

Keywords

Alzheimer’s disease BiP/GRP78 Neuropathology PERK Unfolded protein response 

Notes

Acknowledgements

The authors thank the Netherlands Brain Bank for supplying the human brain tissue (coordinator Dr. R. Ravid), Dr. W. Kamphorst for the neuropathological diagnosis of control and AD tissue, and Marlies Jacobs for her technical assistance. This study was supported by the Internationale Stichting Alzheimer Onderzoek (ISAO grant 02501 to J.H., grant 02504 to W.S.). W.S. is a fellow of the Anton Meelmeijer Center for Translational Research.

References

  1. 1.
    Benn SC, Woolf CJ (2004) Adult neuron survival strategies—slamming on the brakes. Nat Rev Neurosci 5:686–700Google Scholar
  2. 2.
    Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259CrossRefPubMedGoogle Scholar
  3. 3.
    Braak H, Braak E (1995) Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging 16:271–8; discussion 278–284CrossRefPubMedGoogle Scholar
  4. 4.
    Chang RC, Wong AK, Ng HK, Hugon J (2002) Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer’s disease. Neuroreport 13:2429–2432CrossRefPubMedGoogle Scholar
  5. 5.
    Cook DG, Forman MS, Sung JC, Leight S, Kolson DL, Iwatsubo T, Lee VM, Doms RW (1997) Alzheimer’s A beta(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat Med 3:1021–1023Google Scholar
  6. 6.
    Forman MS, Lee VM, Trojanowski JQ (2003) ‘Unfolding’ pathways in neurodegenerative disease. Trends Neurosci 26:407–410CrossRefPubMedGoogle Scholar
  7. 7.
    Hamos JE, Oblas B, Pulaski-Salo D, Welch WJ, Bole DG, Drachman DA (1991) Expression of heat shock proteins in Alzheimer’s disease. Neurology 41:345–350PubMedGoogle Scholar
  8. 8.
    Harding HP, Zhang Y, Ron D (1999) Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397:271–274PubMedGoogle Scholar
  9. 9.
    Hartmann T, Bieger SC, Bruhl B, Tienari PJ, Ida N, Allsop D, Roberts GW, Masters CL, Dotti CG, Unsicker K, Beyreuther K (1997) Distinct sites of intracellular production for Alzheimer’s disease A beta40/42 amyloid peptides. Nat Med 3:1016–1020Google Scholar
  10. 10.
    Katayama T, Imaizumi K, Sato N, Miyoshi K, Kudo T, Hitomi J, Morihara T, Yoneda T, Gomi F, Mori Y, Nakano Y, Takeda J, Tsuda T, Itoyama Y, Murayama O, Takashima A, St George-Hyslop P, Takeda M, Tohyama M (1999) Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat Cell Biol 1:479–485CrossRefPubMedGoogle Scholar
  11. 11.
    Kozutsumi Y, Segal M, Normington K, Gething MJ, Sambrook J (1988) The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 332:462–464Google Scholar
  12. 12.
    Onuki R, Bando Y, Suyama E, Katayama T, Kawasaki H, Baba T, Tohyama M, Taira K (2004) An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer’s disease. EMBO J 23:959–968CrossRefPubMedGoogle Scholar
  13. 13.
    Piccini A, Fassio A, Pasqualetto E, Vitali A, Borghi R, Palmieri D, Nacmias B, Sorbi S, Sitia R, Tabaton M (2004) Fibroblasts from FAD-linked presenilin 1 mutations display a normal unfolded protein response but overproduce Abeta42 in response to tunicamycin. Neurobiol Dis 15:380–386Google Scholar
  14. 14.
    Reisberg B, Ferris SH, Leon MJ de, Crook T (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 139:1136–1139PubMedGoogle Scholar
  15. 15.
    Rutkowski DT, Kaufman RJ (2004) A trip to the ER: coping with stress. Trends Cell Biol 14:20–28CrossRefPubMedGoogle Scholar
  16. 16.
    Sato N, Urano F, Yoon Leem J, Kim SH, Li M, Donoviel D, Bernstein A, Lee AS, Ron D, Veselits ML, Sisodia SS, Thinakaran G (2000) Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression. Nat Cell Biol 2:863–870Google Scholar
  17. 17.
    Scheper W, Hol E (2005) Protein quality control in Alzheimer’s disease: a fatal saviour. Curr Drug Targets CNS Neurol Disord 4:283–292Google Scholar
  18. 18.
    Suen KC, Lin KF, Elyaman W, So KF, Chang RC, Hugon J (2003) Reduction of calcium release from the endoplasmic reticulum could only provide partial neuroprotection against beta-amyloid peptide toxicity. J Neurochem 87:1413–1426PubMedGoogle Scholar
  19. 19.
    Suen KC, Yu MS, So KF, Chang RC, Hugon J (2003) Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine/threonine protein kinase in beta-amyloid peptide neurotoxicity. J Biol Chem 278:49819–49827Google Scholar
  20. 20.
    Taylor JP, Hardy J, Fischbeck KH (2002) Toxic proteins in neurodegenerative disease. Science 296:1991–1995CrossRefPubMedGoogle Scholar
  21. 21.
    Yamaguchi H, Haga C, Hirai S, Nakazato Y, Kosaka K (1990) Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brains by a new methenamine silver stain. Acta Neuropathol 79:569–572CrossRefPubMedGoogle Scholar
  22. 22.
    Yu Z, Luo H, Fu W, Mattson MP (1999) The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of calcium homeostasis. Exp Neurol 155:302–314Google Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • J. J. M. Hoozemans
    • 1
    • 2
    Email author
  • R. Veerhuis
    • 4
  • E. S. Van Haastert
    • 1
    • 2
  • J. M. Rozemuller
    • 2
  • F. Baas
    • 1
    • 3
  • P. Eikelenboom
    • 3
    • 4
  • W. Scheper
    • 1
  1. 1.Neurogenetics Laboratory, Academic Medical CenterUniversity of AmsterdamAmsterdamThe Netherlands
  2. 2.Department of Neuropathology, Academic Medical CenterUniversity of AmsterdamAmsterdamThe Netherlands
  3. 3.Department of Neurology, Academic Medical CenterUniversity of AmsterdamAmsterdamThe Netherlands
  4. 4.Department of PsychiatryVU university medical centerAmsterdamThe Netherlands

Personalised recommendations